ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock
$88.71
价格 · 八月 19, 2026
截至...的财报数据 八月 4, 2026
52周区间
$19–$95
91% of range
分析师评级
BUY
20 analysts
目标价
$110
+24% upside
P/E (TTM)
-9362.7
ROE
-0.50%
净利润率
-0.20%
关于 Arrowhead Pharmaceuticals, Inc. - Common Stock 公司概况（来自维基百科）
ARWR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$88.70
市值
$12.71B
P/E (TTM)
-9362.7
每股收益 (TTM)
$-0.01
营收 (TTM)
$829M
股息收益率
—
ROE
-0.50%
负债/权益
—
52周区间
$19 – $95
ARWR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$829M
2016-09-30
→
2025-09-30
EPS
$-0.01
2017-09-30
→
2025-09-30
自由现金流
$157M
2016-09-30
→
2025-09-30
利润率
-0.20%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ARWR
同行中位数
P/E (TTM)
-9362.7
28.5
P/S (TTM) (市销率 (TTM))
15.3
20.1
P/B (市净率)
27.3
12.9
Price / FCF (股价/自由现金流)
81.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ARWR
同行中位数
Operating Margin (营业利润率)
11.9%
—
Net Profit Margin (净利润率)
-0.20%
-48.4%
ROA
-0.13%
-28.4%
ROE
-0.50%
-49.2%
ROIC
12.3%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ARWR
同行中位数
Current Ratio (流动比率)
4.9
5.0
Quick Ratio (速动比率)
0.0
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ARWR
同行中位数
Revenue YoY (营收同比增长)
23258.2%
—
Revenue CAGR 3Y (营收3年复合年增长率)
50.5%
—
Revenue CAGR 5Y (营收5年复合年增长率)
56.6%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ARWR
同行中位数
ARWR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
20 位分析师
- 强烈买入 6 30.0%
- 买入 13 65.0%
- 持有 1 5.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
11 位分析师 · 2026-08-17
中位数
$104.00
平均值
$110.18
← 低于所有目标
$88.70
最低
$100.00
最高
$126.00
中位数目标
$104.00
+17.2%
平均目标
$110.18
+24.2%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.51%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.36 | $-1.35 | -0.01% |
| 2026年3月31日 | $-0.93 | $-1.21 | 0.28% |
| 2025年12月31日 | $0.22 | $0.26 | -0.04% |
| 2025年9月30日 | $-0.18 | $-0.25 | 0.07% |
| 2025年6月30日 | $-1.26 | $-1.05 | -0.21% |
| 2025年3月31日 | $2.75 | $-0.20 | 3.0% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| R&D Expense | $607M | $506M | $353M | · | · | · | · | · | · | · | $47M | $23M | |
| SG&A Expense | $124M | $99M | $93M | $124M | $81M | $52M | $27M | $19M | $17M | $24M | $8M | $6M | |
| Operating Expenses | $731M | $605M | $446M | $422M | $287M | $181M | $108M | $72M | $68M | $82M | $96M | $53M | |
| Operating Income | $98M | $-601M | $-205M | $-179M | $-149M | $-93M | $61M | $-56M | $-37M | $-82M | $-96M | $-53M | |
| Interest Expense | · | · | $18M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-op | $5M | $-2M | $2M | $765.0K | $2M | $-583.0K | · | $7.5K | $1M | $57.4K | $417.9K | $82.1K | |
| Pretax Income | $52M | $-612M | $-206M | $-173M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Income Tax | $21M | $-3M | $3M | $4M | $2.0K | $2.0K | $174.0K | $2.4K | $2.4K | $2.4K | $2.4K | $5.3K | |
| Net Income | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| EPS (Basic) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.72 | $-0.65 | $-0.47 | · | · | · | |
| EPS (Diluted) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 | $-0.84 | $0.69 | $-0.65 | $-0.47 | · | · | · | |
| Shares (Basic) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 93,859,000 | 83,638,469 | 73,898,598 | · | · | · | |
| Shares (Diluted) | 133,758,000 | 119,784,000 | 106,750,000 | 105,426,000 | 103,745,000 | 100,722,000 | 98,608,000 | 83,638,469 | 73,898,598 | · | · | · | |
| EBITDA | $121M | · | $-194M | $-170M | $-142M | $-89M | $64M | $-56M | $-37M | $-82M | $-96M | $-52M |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | $184M | $144M | $222M | $30M | $25M | $85M | $81M | $133M | |
| Short-term Investments | $693M | · | · | $0 | $127M | $85M | · | · | · | · | · | $22M | |
| Receivables | $7M | $0 | $0 | $1M | $10M | $846.0K | $661.4K | $327.4K | $67.8K | $75.0K | · | · | |
| Prepaid Expense | $11M | $10M | $9M | $7M | $4M | $4M | $3M | $1M | $867.4K | $1M | $3M | $588.6K | |
| Other Current Assets | $14M | $5M | $4M | $20M | $2M | $2M | $3M | $640.1K | $1M | $4M | $823.6K | $48.5K | |
| Current Assets | $951M | $695M | $416M | $405M | $385M | $322M | $265M | $79M | $68M | $91M | $103M | $155M | |
| PP&E (Net) | $383M | $386M | $290M | $110M | $49M | $31M | $23M | $14M | $16M | $15M | $5M | $4M | |
| PP&E (Gross) | $463M | $444M | $332M | $142M | $72M | $47M | $35M | $24M | $23M | $20M | $10M | $8M | |
| Accum. Depreciation | $80M | $58M | $42M | $32M | $23M | $16M | $12M | $10M | $7M | $5M | $5M | $4M | |
| Intangibles | $7M | $9M | $10M | $12M | $14M | $15M | $17M | $19M | $20M | $22M | $25M | $1M | |
| Other Non-current Assets | $1M | $4M | $3M | $218.0K | $272.0K | $264.0K | $144.1K | $141.9K | $141.9K | $122.3K | $45.8K | · | |
| Total Assets | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Accounts Payable | $18M | $11M | $36M | $3M | $9M | $7M | $8M | $3M | $4M | $12M | $5M | $3M | |
| Accrued Liabilities | $90M | $63M | $40M | $47M | $14M | $5M | $7M | $5M | $5M | $5M | $5M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Current Liabilities | $195M | $103M | $105M | $139M | $147M | $41M | $97M | $12M | $19M | $26M | $16M | $12M | |
| Capital Leases | $104M | $111M | $105M | $79M | $23M | $20M | · | · | · | · | $540.8K | $758.3K | |
| Other Non-current Liabilities | · | · | · | $0 | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $255.2K | |
| Total Debt | · | · | · | · | · | · | · | $223.8K | $208.5K | $194.3K | · | $50.0K | |
| Common Stock | $231.0K | $217.0K | $200.0K | $198.0K | $197.0K | $195.0K | $187.9K | $180.9K | $167.2K | $162.1K | $151.9K | $147.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $583M | $514M | $494M | $427M | $391M | |
| Retained Earnings | $-1.63B | $-1.63B | $-1.03B | $-821M | $-645M | $-504M | $-419M | $-487M | $-433M | $-398M | $-317M | $-225M | |
| Treasury Stock | $53M | $0 | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $6M | $5M | $-3M | $-136.0K | $-69.0K | $18.0K | $-391.6K | $-21.6K | $33.2K | $7.4K | $-136.4K | · | |
| Stockholders' Equity | $466M | $185M | $271M | $399M | $409M | $462M | $244M | $95M | $81M | $96M | $110M | $167M | |
| Liabilities + Equity | $1.39B | $1.14B | $766M | $692M | $710M | $523M | $350M | $112M | $104M | $128M | $132M | $183M | |
| Shares Outstanding | 135,702,000 | 124,376,000 | 107,312,000 | 105,960,000 | 104,327,000 | 102,376,000 | 95,506,271 | 88,505,302 | 74,785,726 | 69,746,685 | 59,544,677 | 54,656,936 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $17M | $11M | $9M | $7M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | |
| Stock-based Comp | $63M | $74M | $78M | $121M | $77M | $43M | $12M | $8M | $8M | $12M | $10M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $54.7K | |
| Other Non-cash | $96M | · | $-37M | $-90M | $229M | $-58M | $90M | · | · | · | · | $16M | |
| Operating Cash Flow | $180M | $-463M | $-154M | $-136M | $171M | $-96M | $173M | $-47M | $-24M | $-64M | $-66M | $-35M | |
| CapEx | $23M | $141M | $177M | $53M | $24M | $12M | $12M | $1M | $8M | $4M | $2M | $2M | |
| Investing Cash Flow | $-129M | $-420M | $-96M | $-5M | $-142M | $-241M | $-48M | $-7M | $-49M | $13M | · | · | |
| Stock Issued | $241M | $429M | $0 | $0 | $0 | $250M | $61M | $57M | $12M | $52M | · | $173M | |
| Net Stock Activity | $241M | · | · | $0 | · | $250M | $61M | $57M | $12M | $52M | · | · | |
| Financing Cash Flow | $74M | $871M | $253M | $65M | $11M | $258M | $66M | $60M | $12M | $55M | · | · | |
| Net Change in Cash | · | · | · | · | $41M | $-78M | $192M | $5M | $-61M | $4M | $-51M | $113M | |
| Taxes Paid | $814.0K | $-4M | $0 | $-2.0K | $-2.0K | $103.0K | $-302.0K | $-2.4K | · | · | · | · | |
| Free Cash Flow | $157M | · | $-331M | $-189M | $148M | $-107M | $161M | $-49M | $-32M | $-68M | $-68M | $-37M | |
| Levered FCF | · | · | $-349M | · | · | · | · | · | · | · | · | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | · | -85.2% | -73.4% | -107.8% | -105.9% | 36.2% | -346.5% | -117.8% | -51627.1% | -25124.1% | -30443.6% | |
| Net Margin | -0.20% | · | -85.3% | -72.4% | -101.8% | -96.1% | 40.3% | -337.3% | · | -51614.6% | -24068.3% | -33503.0% | |
| Pretax Margin | 6.2% | · | -85.8% | -71.0% | -101.8% | -96.1% | 40.4% | -337.3% | -109.5% | -51613.1% | -24067.7% | -33554.3% | |
| EBITDA Margin | 14.5% | · | -80.7% | -69.8% | -103.0% | -101.0% | 37.9% | -346.5% | -117.8% | -51627.1% | -25124.1% | -29674.7% | |
| ROA | -0.13% | · | -28.2% | -25.1% | -22.9% | -19.4% | 29.5% | -50.5% | · | -62.8% | -58.4% | -53.3% | |
| ROE | -0.50% | · | -61.3% | -45.7% | -33.0% | -17.7% | 40.0% | -61.5% | · | -79.4% | -66.5% | -60.4% | |
| ROIC | 12.3% | · | -76.6% | -45.8% | -36.5% | -20.2% | 24.9% | -58.3% | -45.3% | -85.4% | -87.1% | -32.0% |
流动性与偿付能力 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | · | 4.0 | 2.9 | 2.6 | 7.9 | 2.7 | 6.4 | 3.6 | 3.5 | 6.5 | 13.1 | |
| Quick Ratio | 0.0 | · | 0.0 | 0.0 | 2.2 | 5.6 | 2.3 | 2.5 | 1.3 | 3.3 | 5.1 | 13.0 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | -11.2 | · | · | · | · | · | · | · | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | · | 0.3 | 0.3 | 0.2 | 0.2 | 0.7 | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 243.1 | · | 341.5 | 41.7 | 24.9 | 116.8 | 341.4 | 81.7 | 439.9 | 2.1 | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23258.2% | -98.5% | -1.0% | 75.9% | 57.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 50.5% | -70.5% | 39.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 56.6% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $829M | $4M | $241M | $243M | $138M | $88M | $169M | $16M | $31M | $158.3K | $382.0K | $175.0K | |
| Net Income TTM | $-2M | $-599M | $-205M | $-176M | $-141M | $-85M | $68M | $-54M | $-34M | $-82M | $-92M | $-59M | |
| Market Cap | $4.68B | · | $2.88B | $3.50B | $6.51B | $4.41B | $2.69B | $1.70B | $324M | $513M | $343M | $807M | |
| Enterprise Value | · | · | · | · | · | · | · | $1.67B | $299M | $427M | · | $653M | |
| P/E | -3449.0 | -3.9 | -14.0 | -19.8 | -45.9 | -51.3 | 40.8 | -29.5 | -9.2 | · | · | · | |
| P/S | 5.6 | · | 12.0 | 14.4 | 47.1 | 50.1 | 15.9 | 105.1 | 10.3 | 3237.7 | 897.8 | 4613.0 | |
| P/B | 10.0 | · | 10.6 | 8.8 | 15.9 | 9.5 | 11.0 | 17.7 | 4.0 | 5.4 | 3.1 | 4.8 | |
| P / Tangible Book | 10.2 | 13.6 | 11.0 | 9.1 | 16.5 | 9.9 | · | · | · | · | · | · | |
| P / Cash Flow | 26.1 | · | -18.7 | -25.7 | 38.0 | -46.2 | 15.6 | -35.9 | -13.5 | -8.0 | -5.2 | -22.8 | |
| P / FCF | 29.8 | · | -8.7 | -18.5 | 44.1 | -41.1 | 16.7 | -34.9 | -10.2 | -7.5 | -5.1 | -21.7 | |
| EV / EBITDA | · | · | · | · | · | · | · | -29.8 | -8.1 | -5.2 | · | -12.6 | |
| EV / FCF | · | · | · | · | · | · | · | -34.3 | -9.4 | -6.3 | · | -17.6 | |
| EV / Revenue | · | · | · | · | · | · | · | 103.3 | 9.5 | 2699.8 | · | 3732.4 | |
| Earnings Yield | -0.03% | -25.8% | -7.1% | -5.1% | -2.2% | -1.9% | 2.5% | -3.4% | -10.8% | · | · | · |
损益表 15
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75M | $74M | $264M | $256M | $28M | $543M | $2M | $0 | $0 | $0 | $4M | $16M | $16M | $146M | $63M | $32M | |
| R&D Expense | $198M | $173M | $177M | $175M | $162M | $133M | $137M | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $47M | $42M | $46M | $38M | $31M | $28M | $27M | $26M | $24M | $25M | $24M | $25M | $24M | $23M | $21M | $32M | |
| Operating Expenses | $245M | $215M | $223M | $212M | $193M | $162M | $164M | $162M | $176M | $126M | $140M | $124M | $119M | $98M | $105M | $115M | |
| Operating Income | $-170M | $-141M | $41M | $44M | $-166M | $381M | $-161M | $-162M | $-176M | $-126M | $-137M | $-108M | $-103M | $48M | $-42M | $-84M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | $5M | · | $5M | $5M | $3M | · | |
| Other Non-op | $1M | $-2M | $277.0K | $5M | $-176.0K | $438.0K | $341.0K | $-3M | $760.0K | $189.0K | $421.0K | $717.0K | $306.0K | $8.0K | $507.0K | $90.0K | |
| Pretax Income | $-179M | $-138M | $28M | $36M | $-179M | $370M | $-175M | $-173M | $-174M | $-127M | $-139M | $-109M | $-103M | $48M | $-42M | $-82M | |
| Income Tax | $11.0K | $7.0K | $29.0K | $20M | $-437.0K | $2M | $103.0K | $546.0K | $0 | $0 | $-3M | $2M | $742.0K | $0 | $17.0K | $4M | |
| Net Income | $-194M | $-133M | $31M | $-24M | $-175M | $370M | $-173M | $-171M | $-171M | $-125M | $-133M | $-110M | $-103M | $49M | $-41M | $-86M | |
| EPS (Basic) | $-1.36 | $-0.93 | $0.22 | $-0.14 | $-1.26 | $2.78 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.03 | $-0.96 | $0.46 | $-0.39 | $-0.81 | |
| EPS (Diluted) | $-1.36 | $-0.93 | $0.22 | $-0.11 | $-1.26 | $2.75 | $-1.39 | $-1.36 | $-1.38 | $-1.02 | $-1.24 | $-1.02 | $-0.96 | $0.45 | $-0.39 | $-0.80 | |
| Shares (Basic) | 143,378,000 | 142,417,000 | 137,039,000 | -263,492,000 | 139,039,000 | 133,363,000 | 124,848,000 | -235,115,000 | 124,199,000 | 123,285,000 | 107,415,000 | -213,050,000 | 107,004,000 | 106,757,000 | 106,039,000 | -210,406,000 | |
| Shares (Diluted) | 143,378,000 | 142,417,000 | 140,706,000 | -264,613,000 | 139,039,000 | 134,484,000 | 124,848,000 | -235,115,000 | 124,199,000 | 123,285,000 | 107,415,000 | -214,436,000 | 107,004,000 | 108,143,000 | 106,039,000 | -212,790,000 | |
| EBITDA | $-164M | $-135M | $47M | · | $-160M | $387M | $-157M | · | $-172M | $-122M | $-133M | · | $-100M | $50M | $-40M | · |
资产负债表 24
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | $69M | $128M | $58M | · | $105M | $135M | $202M | · | |
| Short-term Investments | · | $1.60B | $715M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $9M | $16M | $219M | $7M | $10M | $2M | $2M | $0 | · | · | · | · | $1M | $69M | $40M | · | |
| Prepaid Expense | $25M | $22M | $16M | $11M | $24M | $24M | $9M | $10M | $9M | $11M | $11M | · | $10M | $10M | $8M | · | |
| Other Current Assets | $36M | $18M | $23M | $14M | $13M | $12M | $6M | $5M | $4M | $8M | $7M | · | $7M | $14M | $25M | · | |
| Current Assets | $1.67B | $1.84B | $1.17B | $951M | $947M | $1.14B | $571M | $695M | $450M | $542M | $238M | · | $470M | $575M | $575M | · | |
| PP&E (Net) | $373M | $375M | $379M | $383M | $381M | $385M | $387M | $386M | $376M | $359M | $333M | · | $231M | $185M | $147M | · | |
| PP&E (Gross) | $471M | $466M | $465M | $463M | $455M | $453M | $450M | $444M | $430M | $409M | $379M | · | $270M | $221M | $181M | · | |
| Accum. Depreciation | $97M | $91M | $86M | $80M | $74M | $68M | $63M | $58M | $54M | $50M | $46M | · | $39M | $36M | $34M | · | |
| Intangibles | $6M | $6M | $6M | $7M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | · | $11M | $11M | $12M | · | |
| Other Non-current Assets | $6M | $5M | $1M | $1M | $1M | $1M | $3M | $4M | $4M | $210.0K | $232.0K | · | $210.0K | $210.0K | $210.0K | · | |
| Total Assets | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Accounts Payable | $28M | $31M | $33M | $18M | $33M | $10M | $14M | $11M | $27M | $9M | $4M | · | $8M | $10M | $796.0K | · | |
| Accrued Liabilities | $86M | $77M | $130M | $90M | $65M | $78M | $59M | $63M | $48M | $37M | $47M | · | $38M | $40M | $48M | · | |
| Current Liabilities | $283M | $295M | $347M | $195M | $195M | $221M | $94M | $103M | $97M | $65M | $64M | · | $70M | $87M | $122M | · | |
| Capital Leases | $114M | $100M | $102M | $104M | $106M | $108M | $109M | $111M | $112M | $114M | $115M | · | $80M | $80M | $79M | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $669.0K | · | · | · | |
| Common Stock | $237.0K | $236.0K | $233.0K | $231.0K | $230.0K | $230.0K | $218.0K | $217.0K | $217.0K | $217.0K | $200.0K | · | $199.0K | $199.0K | $199.0K | · | |
| Retained Earnings | $-1.92B | $-1.73B | $-1.60B | $-1.63B | $-1.60B | $-1.43B | $-1.80B | $-1.63B | $-1.45B | $-1.28B | $-1.16B | · | $-916M | $-813M | $-862M | · | |
| Treasury Stock | $53M | $53M | $53M | $53M | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| AOCI | $-1M | $742.0K | $7M | $6M | $5M | $4M | $4M | $5M | $-987.0K | $-1M | $-1M | · | $-411.0K | $-332.0K | $-258.0K | · | |
| Stockholders' Equity | $466M | $614M | $568M | $466M | $522M | $683M | $53M | $185M | $331M | $484M | $160M | · | $365M | $447M | $377M | · | |
| Liabilities + Equity | $2.11B | $2.27B | $1.60B | $1.39B | $1.38B | $1.57B | $1.01B | $1.14B | $884M | $955M | $626M | · | $796M | $891M | $891M | · | |
| Shares Outstanding | 141,135,000 | 140,571,000 | 137,391,000 | 135,702,000 | 138,144,000 | 138,062,000 | 125,572,000 | 124,376,000 | 124,227,000 | 124,133,000 | 107,500,000 | 107,312,000 | 107,102,000 | 106,869,000 | 106,140,000 | · |
现金流 14
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Stock-based Comp | $15M | $17M | $19M | $19M | $13M | $16M | $15M | $19M | $17M | $18M | $20M | $18M | $20M | $21M | $19M | $29M | |
| Amort. of Intangibles | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | $400.0K | $400.0K | $400.0K | $500.0K | |
| Other Non-cash | · | · | $-43M | · | · | · | $7M | · | · | · | $-8M | · | · | · | $-56M | · | |
| Operating Cash Flow | $-177M | $84M | $13M | $20M | $-155M | $460M | $-146M | $-137M | $-115M | $-92M | $-118M | $-26M | $-21M | $-32M | $-76M | $-69M | |
| CapEx | $4M | $3M | $2M | $7M | $2M | $5M | $8M | $24M | $14M | $34M | $69M | $64M | $47M | $27M | $39M | $33M | |
| Investing Cash Flow | $44M | $-894M | $-24M | $73M | $141M | $-420M | $77M | $-223M | $7M | $-269M | $65M | $31M | $-10M | $-36M | $-81M | $36M | |
| Stock Issued | · | · | $47M | $0 | $0 | $241M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | |
| Net Stock Activity | · | · | $47M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-449.0K | $796M | $-15M | $4M | $-43M | $92M | $21M | $389M | $50M | $431M | $267.0K | $821.0K | $1M | $520.0K | $251M | $855.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $-30M | $-67M | $94M | · | |
| Taxes Paid | $22.0K | $12M | $10M | $733.0K | $0 | $92.0K | $11.0K | $-7M | $6M | $4M | $-999.0K | $0 | $0 | $0 | $0 | $-2.0K | |
| Free Cash Flow | · | · | $11M | · | · | · | $-154M | · | · | · | $-186M | · | · | · | $-114M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-192M | · | · | · | · | · |
盈利能力 7
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -191.6% | 15.5% | · | -596.2% | 70.2% | -6456.5% | · | · | · | -3845.2% | · | -649.0% | 32.9% | -67.4% | · | |
| Net Margin | -258.2% | -180.0% | 11.7% | · | -631.1% | 68.3% | -6923.4% | · | · | · | -3741.6% | · | -650.5% | 33.3% | -66.1% | · | |
| Pretax Margin | -237.7% | -186.6% | 10.7% | · | -645.0% | 68.1% | -7004.6% | · | · | · | -3905.6% | · | -653.3% | 32.6% | -66.8% | · | |
| EBITDA Margin | -217.8% | -183.6% | 17.7% | · | -575.3% | 71.3% | -6264.5% | · | · | · | -3738.2% | · | -630.7% | 34.4% | -63.7% | · | |
| ROA | -11.1% | -6.9% | 2.4% | · | -15.5% | 29.3% | -21.1% | · | -20.3% | -13.6% | -17.5% | · | -13.3% | 6.1% | -5.4% | · | |
| ROE | -39.3% | -20.5% | 9.9% | · | -41.1% | 63.5% | -162.5% | · | -49.1% | -26.9% | -49.4% | · | -25.1% | 10.8% | -11.0% | · | |
| ROIC | -36.5% | -23.0% | 7.2% | · | -31.6% | 55.5% | -307.1% | · | -53.3% | -26.1% | -83.1% | · | -28.3% | 10.8% | -11.2% | · |
流动性与偿付能力 3
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.2 | 3.4 | · | 4.9 | 5.1 | 6.1 | · | 4.7 | 8.3 | 3.7 | · | 6.7 | 6.6 | 4.7 | · | |
| Quick Ratio | 0.0 | 5.5 | 2.7 | · | 0.0 | 0.0 | 0.0 | · | 0.7 | 2.0 | 0.9 | · | 1.5 | 2.3 | 2.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.4 | -25.4 | · | -19.9 | 9.5 | · | · |
效率 2
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 | · | 0.0 | 0.4 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | |
| Receivables Turnover | 8.2 | 8.2 | 2.4 | · | 5.1 | 15.1 | 0.1 | · | · | · | · | · | 21.3 | 4.1 | 3.1 | · |
估值 (TTM) 10
| 指标 | 趋势 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $908M | $837M | · | $573M | $545M | $6M | · | $19M | $166M | $228M | · | $257M | $393M | $274M | · | |
| Net Income TTM | $-471M | $93M | $53M | · | $-149M | $-99M | $-602M | · | $-532M | $-312M | $-228M | · | $-168M | $-20M | $-132M | · | |
| Market Cap | $11.50B | $8.81B | $9.12B | · | $2.18B | $1.76B | $2.36B | · | $3.23B | $3.55B | $3.29B | · | $3.82B | $2.71B | $4.31B | · | |
| P/E | -24.5 | 80.4 | 207.5 | · | -12.3 | -12.2 | -3.7 | · | -5.7 | -10.3 | -14.3 | · | -22.6 | -121.0 | -32.2 | · | |
| P/S | 26.1 | 9.7 | 10.9 | · | 3.8 | 3.2 | 390.1 | · | 166.6 | 21.4 | 14.4 | · | 14.9 | 6.9 | 15.7 | · | |
| P/B | 24.7 | 14.4 | 16.0 | · | 4.2 | 2.6 | 44.9 | · | 9.8 | 7.3 | 20.5 | · | 10.5 | 6.1 | 11.4 | · | |
| P / Tangible Book | 25.0 | 14.5 | 16.2 | · | 4.2 | 2.6 | 53.1 | · | 10.0 | 7.5 | 21.8 | · | 10.8 | 6.2 | 11.8 | · | |
| P / Cash Flow | · | · | 676.6 | · | · | · | -16.1 | · | · | · | -27.9 | · | · | · | -57.0 | · | |
| P / FCF | · | · | 804.9 | · | · | · | -15.4 | · | · | · | -17.6 | · | · | · | -37.6 | · | |
| Earnings Yield | -4.1% | 1.2% | 0.48% | · | -8.1% | -8.2% | -26.8% | · | -17.7% | -9.7% | -7.0% | · | -4.4% | -0.83% | -3.1% | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| 收入 | $829M | $4M | $241M | $243M | $138M |
| 营业利润率 % | 11.9% | — | -85.2% | -73.4% | -107.8% |
| 净收入 | $-2M | $-599M | $-205M | $-176M | $-141M |
| 稀释后每股收益 (EPS) | $-0.01 | $-5.00 | $-1.92 | $-1.67 | $-1.36 |
资产负债表
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| 流动比率 | 4.9 | — | 4.0 | 2.9 | 2.6 |
| 速动比率 | 0.0 | — | 0.0 | 0.0 | 2.2 |
现金流
| 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | |
|---|---|---|---|---|---|
| 自由现金流 | $157M | — | $-331M | $-189M | $148M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 535 家申报者 · $7.8B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 129 (+17 与上一季度对比) | 54 (-1 与上一季度对比) | 150 (-3 与上一季度对比) | 159 (+27 与上一季度对比) | +18.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $940062881 | 14159706 | 11.99% | 股份 |
| Avoro Capital Advisors LLC | $925591288 | 11355555 | 11.80% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $517698946 | 6351355 | 6.60% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $498103779 | 6110953 | 6.35% | 股份 |
| STATE STREET CORP | $464170106 | 5694640 | 5.92% | 股份 |
| FMR LLC | $392073778 | 4810131 | 5.00% | 股份 |
| NORGES BANK | $317606649 | 3896536 | 4.05% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $269139418 | 3301919 | 3.43% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $254549119 | 2987563 | 3.25% | 股份 |
| BAKER BROS. ADVISORS LP | $162431742 | 1992783 | 2.07% | 股份 |
| Siren, L.L.C. | $139828449 | 1715476 | 1.78% | 股份 |
| Vestal Point Capital, LP | $128378250 | 1575000 | 1.64% | 股份 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $113221873 | 1389055 | 1.44% | 股份 |
| FIRST TRUST ADVISORS LP | $110276346 | 1352918 | 1.41% | 股份 |
| Driehaus Capital Management LLC | $110083820 | 1350556 | 1.40% | 股份 |
| Hood River Capital Management LLC | $91352088 | 1120747 | 1.16% | 股份 |
| Holocene Advisors, LP | $90164487 | 1106177 | 1.15% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $87578827 | 1074455 | 1.12% | 股份 |
| Fisher Asset Management, LLC | $78061392 | 957691 | 1.00% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $75309290 | 923927 | 0.96% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $73093114 | 896738 | 0.93% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $70718076 | 867600 | 0.90% | 买入期权 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $67673433 | 830247 | 0.86% | 股份 |
| Western Financial Corp/CA | $66857681 | 820239 | 0.85% | 股份 |
| GOLDMAN SACHS GROUP INC | $55222862 | 677498 | 0.70% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $50990129 | 625569 | 0.65% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48626665 | 596573 | 0.62% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $47325440 | 580609 | 0.60% | 股份 |
| Pictet Asset Management Holding SA | $46708118 | 573419 | 0.60% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $45534991 | 558643 | 0.58% | 股份 |
| 1832 Asset Management L.P. | $43893135 | 538500 | 0.56% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $41902905 | 514083 | 0.53% | 股份 |
| Balyasny Asset Management L.P. | $38370343 | 470744 | 0.49% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $38221751 | 468921 | 0.49% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $34600995 | 424500 | 0.44% | 卖出期权 |
| RHUMBLINE ADVISERS | $30557778 | 374897 | 0.39% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $30158700 | 370000 | 0.38% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $29687001 | 364211 | 0.38% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $26844259 | 329337 | 0.34% | 股份 |
| Caption Management, LLC | $25724556 | 315600 | 0.33% | 买入期权 |
| LPL Financial LLC | $25330147 | 310761 | 0.32% | 股份 |
| Artisan Partners Limited Partnership | $25325646 | 310706 | 0.32% | 股份 |
| CITADEL ADVISORS LLC | $21755019 | 266900 | 0.28% | 买入期权 |
| BANK OF AMERICA CORP /DE/ | $21066994 | 258459 | 0.27% | 股份 |
| California Public Employees Retirement System | $20892154 | 256314 | 0.27% | 股份 |
| Squarepoint Ops LLC | $20858980 | 255907 | 0.27% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $20722128 | 254228 | 0.26% | 股份 |
| Aberdeen Group plc | $20537912 | 251968 | 0.26% | 股份 |
| Swiss National Bank | $19472739 | 238900 | 0.25% | 股份 |
| Privium Fund Management B.V. | $19091435 | 234222 | 0.24% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17780021 | 218133 | 0.23% | 股份 |
| Life Cycle Investment Partners Ltd | $17041133 | 209068 | 0.22% | 股份 |
| UBS Group AG | $16742806 | 205408 | 0.21% | 股份 |
| Assenagon Asset Management S.A. | $16459070 | 201927 | 0.21% | 股份 |
| Woodline Partners LP | $16316998 | 200184 | 0.21% | 股份 |
| Integral Health Asset Management, LLC | $16302000 | 200000 | 0.21% | 股份 |
| BlackRock, Inc. | $16111919 | 197668 | 0.21% | 股份 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $15603622 | 191432 | 0.20% | 股份 |
| PINNACLE ASSOCIATES LTD | $13867378 | 170131 | 0.18% | 股份 |
| WCM INVESTMENT MANAGEMENT, LLC | $13784176 | 171232 | 0.18% | 股份 |
| SEB Asset Management AB | $12895265 | 158205 | 0.16% | 股份 |
| Clearbridge Investments, LLC | $12806043 | 157110 | 0.16% | 股份 |
| Affinity Asset Advisors, LLC | $12226500 | 150000 | 0.16% | 股份 |
| AMERIPRISE FINANCIAL INC | $12132846 | 148851 | 0.15% | 股份 |
| WEALTH EFFECTS LLC | $12006423 | 147300 | 0.15% | 股份 |
| Retirement Systems of Alabama | $11874947 | 145687 | 0.15% | 股份 |
| HighTower Advisors, LLC | $11443515 | 140394 | 0.15% | 股份 |
| JANE STREET GROUP, LLC | $11134266 | 136600 | 0.14% | 买入期权 |
| Weiss Asset Management LP | $10923481 | 134014 | 0.14% | 股份 |
| BANK OF NOVA SCOTIA | $10906451 | 133805 | 0.14% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $10863716 | 173265 | 0.14% | 股份 |
| PFM Health Sciences, LP | $10732177 | 131667 | 0.14% | 股份 |
| Tetragon Partners GP Ltd | $10635751 | 130484 | 0.14% | 股份 |
| JPMORGAN CHASE & CO | $10476675 | 130145 | 0.13% | 股份 |
| Rhenman & Partners Asset Management AB | $10433280 | 128000 | 0.13% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $9708004 | 119102 | 0.12% | 股份 |
| Catalyst Funds Management Pty Ltd | $9585576 | 117600 | 0.12% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $9487193 | 116393 | 0.12% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $9125452 | 111955 | 0.12% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9048425 | 144313 | 0.12% | 股份 |
| SEI INVESTMENTS CO | $8993976 | 110342 | 0.11% | 股份 |
| ACT CAPITAL MANAGEMENT, LLC | $8974251 | 110100 | 0.11% | 股份 |
| HSBC HOLDINGS PLC | $8966100 | 110000 | 0.11% | 股份 |
| D. E. Shaw & Co., Inc. | $8904397 | 109243 | 0.11% | 股份 |
| Empowered Funds, LLC | $8806422 | 108041 | 0.11% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8503286 | 104322 | 0.11% | 股份 |
| Nuveen, LLC | $8446474 | 103625 | 0.11% | 股份 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8445740 | 103616 | 0.11% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $8209443 | 100717 | 0.10% | 股份 |
| JANE STREET GROUP, LLC | $8167302 | 100200 | 0.10% | 卖出期权 |
| Ikarian Capital, LLC | $8151000 | 100000 | 0.10% | 卖出期权 |
| Dorsey Wright & Associates | $7944454 | 97466 | 0.10% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $7785428 | 95515 | 0.10% | 股份 |
| KEYSTONE INVESTORS PTE LTD | $7715818 | 94661 | 0.10% | 股份 |
| Legal & General Group Plc | $7248684 | 88930 | 0.09% | 股份 |
| JANE STREET GROUP, LLC | $7194154 | 88261 | 0.09% | 股份 |
| Aquilo Capital Management, LLC | $7008656 | 550130 | 0.09% | 股份 |
| VOYA INVESTMENT MANAGEMENT LLC | $6828256 | 83772 | 0.09% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $6374082 | 78200 | 0.08% | 买入期权 |
| Transamerica Financial Advisors, LLC | $6309121 | 77403 | 0.08% | 股份 |
公司内部人士 32 位内幕人士 · 16 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Christopher Richard Anzalone | Chief Executive Officer | 2022年12月20日 A | 3720714 | 0 | 0 | $0 |
| Daniel Joseph Apel | Chief Financial Officer | 2026年4月22日 S | 162905 | 0 | 3 | $-934286 |
| Kenneth Allen Myszkowski | Chief Financial Officer | 2023年1月4日 A | 396704 | 0 | 0 | $0 |
| McDonnel Paul Clayton | CFO (former) | 2009年7月17日 J | — | 0 | 0 | $0 |
| Joseph Theodore Kingsley III | Chief Financial Officer | 2007年3月29日 A | 12000 | 0 | 0 | $0 |
| Leon Ekchian | President | 2005年11月14日 A | — | 0 | 0 | $0 |
| Patrick O'Brien | COO and General Counsel | 2023年1月5日 S | 413375 | 0 | 0 | $0 |
| Bruce D Given | Chief Operating Officer | 2020年4月28日 M | 850730 | 0 | 0 | $0 |
| Tracie Oliver | Chief Commercial Officer | 2023年1月4日 A | 70500 | 0 | 0 | $0 |
| Javier San Martin | Chief Medical Officer | 2023年1月4日 A | 151500 | 0 | 0 | $0 |
| Curt Bradshaw | Chief Scientific Officer | 2020年11月20日 S | 0 | 0 | 0 | $0 |
| Zhen Li | Snr. VP, Chem and Non-Clin Dev | 2019年1月14日 S | 201700 | 0 | 0 | $0 |
| Peter Brian Leone | VP, Strategic Bus. Initiatives | 2018年10月19日 M | 130000 | 0 | 0 | $0 |
| David L. Lewis | Chief Scientific Officer | 2016年1月1日 A | 0 | 0 | 0 | $0 |
| STEWART R BRUCE | Executive Chairman | 2010年3月4日 A | 711500 | 0 | 0 | $0 |
| James M Phillips JR | Secretary | 2004年3月31日 A | — | 0 | 0 | $0 |
| Matthew Gregory Cohen | 董事 | 2026年6月15日 A | 11882 | 0 | 0 | $0 |
| Douglas S Ingram | 董事 | 2025年12月16日 A | 46215 | 0 | 0 | $0 |
| Douglas B Given | 董事 | 2023年2月27日 S | 13000 | 0 | 0 | $0 |
| Victoria Vakiener | 董事 | 2023年1月10日 A | 23284 | 0 | 0 | $0 |
| Marianne De Backer | 董事 | 2023年1月10日 A | 31267 | 0 | 0 | $0 |
| William D. Waddill | 董事 | 2023年1月10日 A | 36817 | 0 | 0 | $0 |
| Mauro Ferrari | 董事 | 2023年1月10日 A | 50838 | 0 | 0 | $0 |
| Edward W Frykman | 董事 | 2018年1月1日 A | 148852 | 0 | 0 | $0 |
| Charles Mckenney | 董事 | 2015年3月4日 A | 42220 | 0 | 0 | $0 |
| Leroy T Rahn | 董事 | 2010年3月4日 A | — | 0 | 0 | $0 |
| David M Knott | 10% 所有者 | 2007年3月21日 S | 742600 | 0 | 0 | $0 |
| Marshall Robert Ching | 10% 所有者 | 2005年6月23日 U | 28666 | 0 | 0 | $0 |
| Adeoye Y Olukotun | — | 2025年12月19日 S | 33600 | 0 | 3 | $-676623 |
| Michael S Perry | — | 2025年12月16日 A | 123059 | 0 | 1 | $-991738 |
| James C Hamilton | — | 2023年1月5日 S | 191484 | 0 | 0 | $0 |
| James Hassard | — | 2021年6月22日 S | 105750 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 3 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc., Sarepta Therapeutics Investments, Inc. ×2 申报 | 2025年8月15日 | 0.00% | 修订 | — | SEC |
| Silence Therapeutics Plc ×3 申报 | 2017年12月8日 | — | 初始申报 | — | SEC |
| Novartis Institutes for BioMedical Research, Inc., Novartis AG ×2 申报 | 2017年11月28日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 95 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 4.47% | 4021 SH | 2026年8月8日 | 每日 |
| GNOM · Global X Funds | 4.07% | 29150 NS | 2026年5月31日 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2.56% | 18591 NS | 2026年4月30日 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 2.46% | 100744 SH | 2026年8月8日 | 每日 |
| XMMO · Invesco Exchange-Traded Fund Trust | 2.02% | 1737614 SH | 2026年8月8日 | 每日 |
| PTH · Invesco Exchange-Traded Fund Trust | 2.01% | 56530 SH | 2026年8月8日 | 每日 |
| BBP · ETFis Series Trust I | 1.67% | 13501 NS | 2026年4月30日 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 1.37% | 236149 SH | 2026年8月8日 | 每日 |
| LABU · Direxion Shares ETF Trust | 1.18% | 83558 NS | 2026年4月30日 | N-PORT |
| HRTS · Tema ETF Trust | 1.09% | 7240 NS | 2026年5月31日 | N-PORT |
| PAMC · Pacer Funds Trust | 0.88% | 7520 NS | 2026年4月30日 | N-PORT |
| IBB · iShares Trust | 0.88% | 971687 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.84% | 7664 SH | 2026年8月8日 | 每日 |
| FNY · First Trust Exchange-Traded Alpha... | 0.78% | 54678 NS | 2026年4月30日 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0.71% | 95209 NS | 2026年4月30日 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.67% | 76377 NS | 2026年4月30日 | N-PORT |
| IJK · iShares Trust | 0.65% | 824470 SH | 2026年8月8日 | 每日 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.60% | 138986 SH | 2026年8月8日 | 每日 |
| JSML · Janus Detroit Street Trust | 0.58% | 24940 NS | 2026年4月30日 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 0.56% | 335 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.55% | 5178 NS | 2026年5月31日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund ... | 0.49% | 3305 NS | 2026年5月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.46% | 46300 NS | 2026年4月30日 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trus... | 0.41% | 20520 SH | 2026年8月8日 | 每日 |
| XJH · iShares Trust | 0.38% | 19017 SH | 2026年8月8日 | 每日 |
| IQSM · New York Life Investments ETF Trust | 0.35% | 15065 NS | 2026年4月30日 | N-PORT |
| IJH · iShares Trust | 0.33% | 4860150 SH | 2026年8月8日 | 每日 |
| BFOR · ALPS ETF Trust | 0.33% | 9046 NS | 2026年5月31日 | N-PORT |
| FNX · First Trust Exchange-Traded Alpha... | 0.32% | 58042 NS | 2026年4月30日 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.31% | 227611 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.30% | 58609 NS | 2026年4月30日 | N-PORT |
| PTMC · Pacer Funds Trust | 0.30% | 16068 NS | 2026年4月30日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.30% | 1772235 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.27% | 67223 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.26% | 6367 NS | 2026年5月31日 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 0.26% | 44 NS | 2026年4月30日 | N-PORT |
| MVV · ProShares Trust | 0.24% | 4843 NS | 2026年5月31日 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.23% | 18551 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.23% | 673375 NS | 2026年5月31日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.23% | 15031 NS | 2026年4月30日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.22% | 70532 NS | 2026年4月30日 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.22% | 18456 NS | 2026年4月30日 | N-PORT |
| ISCG · iShares Trust | 0.21% | 24448 SH | 2026年8月8日 | 每日 |
| IWP · iShares Trust | 0.21% | 490695 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.20% | 67415 SH | 2026年8月8日 | 每日 |
| MIDU · Direxion Shares ETF Trust | 0.20% | 2319 NS | 2026年4月30日 | N-PORT |
| IYH · iShares Trust | 0.19% | 80786 SH | 2026年8月8日 | 每日 |
| UMDD · ProShares Trust | 0.17% | 676 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.16% | 5471 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.16% | 4980 NS | 2026年5月31日 | N-PORT |